SCHEMBL1783706

SCHEMBL1783706

CCCCCC=COC(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.48
ALDH1A1 P00352 5/20 0.48
PPARD Q03181 4/20 0.48
PPARA Q07869 4/20 0.48
F7 P08709 4/20 0.48
F3 P13726 4/20 0.48
FFAR1 O14842 3/20 0.48
KDM4E B2RXH2 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP19A1 P11511 2/20 0.48
FABP4 P15090 2/20 0.48
HPGD P15428 2/20 0.48
ALOX15 P16050 2/20 0.48
NR4A2 P43354 2/20 0.48
HSD17B10 Q99714 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
PTGS1 P23219 2/20 0.48
AKR1C3 P42330 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1783705 1.00 PPARG (0.48) PPARGALDH1A1PPARDPPARAF7
SCHEMBL11743791 0.98 HSD17B10 (0.50) PPARGALDH1A1PPARDPPARAF7
SCHEMBL1300936 0.98 HSD17B10 (0.50) PPARGALDH1A1PPARDPPARAF7
SCHEMBL1301683 0.98 HSD17B10 (0.50) PPARGALDH1A1PPARDPPARAF7
SCHEMBL593168 0.98 HSD17B10 (0.50) PPARGALDH1A1PPARDPPARAF7
SCHEMBL25407500 0.98 HSD17B10 (0.50) PPARGALDH1A1PPARDPPARAF7
SCHEMBL833124 0.98 HSD17B10 (0.50) PPARGALDH1A1PPARDPPARAF7
SCHEMBL20503632 0.98 HSD17B10 (0.50) PPARGALDH1A1PPARDPPARAF7
SCHEMBL20636558 0.98 HSD17B10 (0.50) PPARGALDH1A1PPARDPPARAF7
SCHEMBL592267 0.98 HSD17B10 (0.50) PPARGALDH1A1PPARDPPARAF7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119563654-A Bactrocera dorsalis attractant and preparation method and application thereof 南京新安中绿生物科技有限公司 2025-03-07 CN claimed
US-20190155975-A9 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions THE PROCTER & GAMBLE COMPANY 2019-05-23 US claimed
US-10240108-B2 Particles for malodor reduction THE PROCTER & GAMBLE COMPANY (US) 2019-03-26 US claimed
US-10113140-B2 Freshening compositions and devices comprising same THE PROCTER & GAMBLE COMPANY (US) 2018-10-30 US claimed
EP-3365418-A2 PARTICLES FOR MALODOR REDUCTION The Procter and Gamble Company (US) 2018-08-29 EP claimed
US-20180004875-A1 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions THE PROCTER & GAMBLE COMPANY 2018-01-04 US claimed
US-20170333591-A9 ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2017-11-23 US claimed
US-20170275564-A1 PARTICLES FOR MALODOR REDUCTION PROCTER & GAMBLE (US) 2017-09-28 US claimed
US-20170249407-A1 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions THE PROCTER & GAMBLE COMPANY 2017-08-31 US claimed
US-20170249408-A1 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions THE PROCTER & GAMBLE COMPANY 2017-08-31 US claimed
WO-2016049395-A1 PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20160090556-A1 PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
WO-2016049455-A1 PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049407-A1 ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049394-A1 CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20160090555-A1 CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
US-20160090557-A1 SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
WO-2016049404-A1 SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049397-A1 FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170249408-A1 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions LPO, QDPR, TYR PPARG 1140/4885ALDH1A1 252/4885PPARD 630/4885
US-20170249407-A1 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions LPO, QDPR, TYR PPARG 1119/4885ALDH1A1 260/4885PPARD 583/4885
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS LPO, QDPR, TYR PPARG 1140/4885ALDH1A1 252/4885PPARD 630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.